Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 1761-1770 Newer>

The Motley Fool February 11, 2005 Stephen D. Simpson	Laser Beamer Lookin' Good Palomar continues to build a profitable business in the highly competitive cosmetic laser market.
BusinessWeek February 21, 2005 Gene G. Marcial	Iridex May Open More Investors' Eyes Iridex's stock price has fluctuated since initial results of clinical trials on its transpupillary thermotherapy product for age-related [wet] macular degeneration, a leading cause of blindness.
InternetNews February 10, 2005 Tim Gray	Microsoft and Pfizer After Viagra Spammers Redmond and the pharmaceutical giant team up to file lawsuits to fight selling and advertising of knock-off drugs.
The Motley Fool February 10, 2005 Charly Travers	Focus on the Pipeline Vertex Pharmaceuticals is losing money. But it has at least one drug that makes the future look brighter.
The Motley Fool February 10, 2005 Brian Gorman	Automakers Roll Out a SEMI GM, Ford, and DaimlerChrysler are collaborating to slow drug-cost increases.
The Motley Fool February 10, 2005 Karl Thiel	The Worst Has Happened. Time to Sell? Biotech stocks can be volatile, but dumping them in response to bad news isn't always the smartest option: Axonyx... Icos Pharmaceuticals... etc.
The Motley Fool February 9, 2005 Stephen D. Simpson	Intuitive Surgical Is a Cut Above The maker of medical robots offers hot growth and a red-hot valuation to match.
The Motley Fool February 9, 2005 Stephen D. Simpson	PolyMedica Retrenches Embattled direct-to-consumer medical products provider looks to rebound from setbacks. Valuation now appears a bit rich for a company that won't really be growing much for the next year or two.
IndustryWeek February 1, 2005 Aaron Dalton	Strength Through Flexibility New headquarters for growing medical products manufacturer Stryker Orthopaedics can accommodate the future. The company built its entire manufacturing floor on a grid system that allows plug-and-play movement of entire cells.
The Motley Fool February 8, 2005 Charly Travers	Good Prognosis for Biogen IDEC Blockbuster products help the biotech firm continue its stellar performance.
<Older 1761-1770 Newer> Return to current articles.